The previously cloned Bacillus subtilis lipase gene (lip) was mapped on the chromosome and used in the construction of a B. subtilis derivative totally devoid of any lip sequence. detergents (2, 12) . The Bacillus subtilis 168 lipase has become an attractive enzyme for industrial applications: (i) expression of the cloned gene in Escherichia coli showed that it exhibits a broad substrate range which includes various-chain-length p-nitrophenyl esters and triglycerides; and (ii) nucleotide and deduced amino acid sequences predicted a remarkably alkaline pl of 9.73 and rather low Mrs of 22,777 and 19,348 for the native and mature proteins, respectively (3). Thus, the B. subtilis enzyme is one of the smallest lipases described so far.
Lipases (triacylglycerol acylhydrolases; EC 3.1.1.3) are a class of enzymes which are able to hydrolyze ester bonds of triglyceride substrates at oil-water interfaces. This unique feature separates lipases from closely related hydrolytic enzymes such as esterases, although several lipases were shown recently to hydrolyze water-soluble substrates with varying efficiencies (1, 5, 8, 11) .
Microbial lipases vary widely in enzymatic properties and substrate specificities. Consequently, they are currently receiving much attention because of their potential applications in various industrial processes. For example, alkaline pH-resistant lipases are currently used as additives in detergents (2, 12) . The Bacillus subtilis 168 lipase has become an attractive enzyme for industrial applications: (i) expression of the cloned gene in Escherichia coli showed that it exhibits a broad substrate range which includes various-chain-length p-nitrophenyl esters and triglycerides; and (ii) nucleotide and deduced amino acid sequences predicted a remarkably alkaline pl of 9.73 and rather low Mrs of 22,777 and 19,348 for the native and mature proteins, respectively (3). Thus, the B. subtilis enzyme is one of the smallest lipases described so far.
B. subtilis has long been used in industry for the production of secretory proteins. Because of its nonpathogenic nature and high secretion capacity and the existence of a great deal of fermentation technology, B. subtilis has been regarded as an attractive host for the secretion of endogenous as well as heterologous proteins (6) . Hence, our work has been directed towards genetic analysis and overexpression of lipolytic activity in B. subtilis to allow further purification and characterization in a homologous system (11 subtilis, was replaced by the pAT21.1 aphA gene (14) conferring kanamycin resistance in gram-positive bacteria (Fig. la) . After PstI linearization of the recombinant plasmid (pLIP21), the DNA was used to transform the B. subtilis proteasedeficient strain DB104, with selection for kanamycin resistance (Fig. lb) . The resulting strain, designated BCL1008, displayed a lipase-negative phenotype when plated on triolein-rhodamine medium, which contains the following, per liter of LB agar: 31.25 ml of purified olive oil and 10 ml of a 1-mg/ml rhodamine B solution, emulsified by mixing for 1 min in a domestic mixer (9 (Fig. 2a) . The resulting plasmid, pLIP2002 (Alip), retained the chromosomal 600-and 800-bp lip flanking regions at the 5' and 3' ends, respectively. Plasmid pLIP2002 was linearized and used to transform B. subtilis BCL1008 (lip::Km) in combination with a chloramphenicol resistance (Cmr) gene inserted into an arbitrary chromosomal fragment (estB in the present case) from B. subtilis (Fig. 2b) . (Fig. 3a) . Amplification products were first phosphorylated and bulk ligated to avoid problems of cleavage close to the end of the DNA fragments. The ligation mixture was subjected to KpnI-HindIHI digestion, and resulting fragments were subcloned at the same sites of the pMA5 E. coli-B. subtilis shuttle vector (16) . Recombinant plasmid pLIP2030 was isolated following electrotransformation into E. coli TG1 (13) . SstI digestion of pLIP2030 followed by self-ligation removed the E. coli replicon and positioned the lip ORF just downstream of the strong gram-positive HpaII promoter (16) (Fig. 3b) . The shortened plasmid was designated pLIP2031 and was used to transform the B. subtilis Alip strain BCL1050 under Kmr selection. Lipase activity of late-exponential-phase cultures of the resulting strain, BCL1051, was about 100-fold greater than the wild-type strain activity: 17 U/mg of protein in culture supernatant with p-nitrophenyl-palmitate as the substrate, under standard conditions (11) .
The B. subtilis overexpressing strain BCL1051 currently is being used to purify lipase from culture supernatants. Such a homologous system offers the following advantages for optimal purification, characterization, or industrial purposes: (i) efficient protein secretion, (ii) correct maturation of the enzyme, (iii) improved stability of the lipase due to the lack of two major proteases in the culture supernatant of the DB104 host strain, and (iv) the generally regarded as safe (GRAS) status of the B. subtilis species. In addition, B. subtilis may represent the only potential host for endogenous lipase overproduction since it possesses a membrane-bound inhibitor which protects the membrane from lipolytic activity (10) . It has been suggested that expression of the B. subtilis lipase gene inhibits the development and growth of E. coli cells (3) . Consequently, the Alip strain BCL1050 could stimulate an interest in the cloning of heterologous lipase genes for industrial applications. Cloning and overexpression of the thermostable lipase from B. stearothermophilus are in progress.
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